Improving decision making in larynx cancer by developing a decision aid: A mixed methods approach

Japke F Petersen, Adriana Berlanga, Martijn M Stuiver, Olga Hamming-Vrieze, Frank Hoebers, Philippe Lambin, Michiel W M van den Brekel, Japke F Petersen, Adriana Berlanga, Martijn M Stuiver, Olga Hamming-Vrieze, Frank Hoebers, Philippe Lambin, Michiel W M van den Brekel

Abstract

Objective: Patients diagnosed with advanced larynx cancer face a decisional process in which they can choose between radiotherapy, chemoradiotherapy, or a total laryngectomy with adjuvant radiotherapy. Clinicians do not always agree on the best clinical treatment, making the decisional process for patients a complex problem.

Methods: Guided by the International Patient Decision Aid (PDA) Standards, we followed three developmental phases for which we held semi-structured in-depth interviews with patients and physicians, thinking-out-loud sessions, and a study-specific questionnaire. Audio-recorded interviews were verbatim transcribed, thematically coded, and analyzed. Phase 1 consisted of an evaluation of the decisional needs and the regular counseling process; phase 2 tested the comprehensibility and usability of the PDA; and phase 3 beta tested the feasibility of the PDA.

Results: Patients and doctors agreed on the need for development of a PDA. Major revisions were conducted after phase 1 to improve the readability and replace the majority of text with video animations. Patients and physicians considered the PDA to be a major improvement to the current counseling process.

Conclusion: This study describes the development of a comprehensible and easy-to-use online patient decision aid for advanced larynx cancer, which was found satisfactory by patients and physicians (available on www.treatmentchoice.info). The outcome of the interviews underscores the need for better patient counseling. The feasibility and satisfaction among newly diagnosed patients as well as doctors will need to be proven. To this end, we started a multicenter trial evaluating the PDA in clinical practice (ClinicalTrials.gov Identifier: NCT03292341).

Level of evidence: NA Laryngoscope, 129:2733-2739, 2019.

Keywords: Patient decision aid; chemoradiotherapy; counseling; health communication; laryngectomy; larynx cancer; radiotherapy.

© 2019 The Authors. The Laryngoscope published by Wiley Periodicals, Inc. on behalf of The American Laryngological, Rhinological and Otological Society, Inc.

Figures

Figure 1
Figure 1
Developmental process. Flowchart of the developmental process of the PDA (analogy of IPDAS checklist).21 IPDAS = International Patient Decision Aid Standards; PDA = Patient Decision Aid.
Figure 2
Figure 2
Layout of the first version of the PDA. (A) Home page of the PDA. For each treatment option, we included videos of doctors explaining the treatment and videos of patients who are interviewed on their decisional process, the treatment, and their quality of life. (B) The PDA contains a short summary with the risks and benefits of each option laid out next to each other and estimated overall survival rates per treatment and tumor characteristics (based on the tumor‐node‐metastasis classification). (C) All the treatment options are explained using text, pictures, and videos (D). At the end, patients can fill in a knowledge and preference test. They are encouraged to take the results of these tests to their physician to identify potential gaps in their knowledge and discuss personal preferences. PDA = Patient Decision Aid.
Figure 3
Figure 3
Layout of the final version of the PDA. With the results of the interviews, major changes were made. The majority of text was replaced by animation videos (A, B) explaining the details of all the different treatment options, and textual corrections suggested by the physicians were adjusted. We added a voic‐over so patients would not have to read the text, and the structure of the PDA is now explained at the homepage with an introduction animation video. (C) Large texts were summarized, but the more comprehensive text was still available on request via an extra information button. (D) Furthermore, bright colors were replaced with blue and white tones. An extra patient video was added. PDA = Patient Decision Aid.

References

    1. Lambin P, van Stiphout RG, Starmans MH, et al. Predicting outcomes in radiation oncology—multifactorial decision support systems. Nat Rev Clin Oncol 2013;10:27–40.
    1. Lambin P, Zindler J, Vanneste BG, et al. Decision support systems for personalized and participative radiation oncology. Adv Drug Deliv Rev 2017;109:131–153.
    1. Charles C, Gafni A, Whelan T. Shared decision‐making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med 1997;44:681–692.
    1. Legare F, Stacey D, Turcotte S, et al. Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane Database Syst Rev 2014:CD006732.
    1. Basch E. Patient‐reported outcomes—harnessing patients' voices to improve clinical care. N Engl J Med 2017;376:105–108.
    1. Stewart MA. Effective physician‐patient communication and health outcomes: a review. CMAJ 1995;152:1423–1433.
    1. Stacey D, Legare F, Col NF, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2014;1:CD001431.
    1. Llewellyn CD, McGurk M, Weinman J. How satisfied are head and neck cancer (HNC) patients with the information they receive pre‐treatment? Results from the satisfaction with cancer information profile (SCIP). Oral Oncol 2006;42:726–734.
    1. Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient‐reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 2016;34:557–565.
    1. Fowler FJ Jr, Levin CA, Sepucha KR. Informing and involving patients to improve the quality of medical decisions. Health Aff (Millwood) 2011;30:699–706.
    1. Fitzgerald E, Perry A. Pre‐operative counselling for laryngectomy patients: a systematic review. J Laryngol Otol 2016;130:15–20.
    1. Hahlweg P, Harter M, Nestoriuc Y, Scholl I. How are decisions made in cancer care? A qualitative study using participant observation of current practice. BMJ Open 2017;7:e016360.
    1. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer . The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324:1685–1690.
    1. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006;116:1–13.
    1. Timmermans AJ, van Dijk BA, Overbeek LI, et al. Trends in treatment and survival for advanced laryngeal cancer: A 20‐year population‐based study in The Netherlands. Head Neck 2016;38(suppl 1):E1247–E1255.
    1. Forastiere AA, Ismaila N, Wolf GT. Use of larynx‐preservation strategies in the treatment of laryngeal cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary. J Oncol Pract 2018;14:123–128.
    1. Kuo P, Chen MM, Decker RH, Yarbrough WG, Judson BL. Hypopharyngeal cancer incidence, treatment, and survival: temporal trends in the United States. Laryngoscope 2014;124:2064–2069.
    1. McNeil BJ, Weichselbaum R, Pauker SG. Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med 1981;305:982–987.
    1. Theunissen EA, Timmermans AJ, Zuur CL, et al. Total laryngectomy for a dysfunctional larynx after (chemo)radiotherapy. Arch Otolaryngol Head Neck Surg 2012;138:548–555.
    1. Elwyn G, O'Connor A, Stacey D, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 2006;333:417.
    1. Elwyn G, Kreuwel I, Durand MA, et al. How to develop web‐based decision support interventions for patients: a process map. Patient Educ Couns 2011;82:260–265.
    1. Stafford ND, Lewin RJ, Nash P, Hardman GF. Surgeon information giving practices prior to laryngectomy: a national survey. Ann R Coll Surg Engl 2001;83:371–375.
    1. Hamilton DW, Pedersen A, Blanchford H, et al. A comparison of attitudes to laryngeal cancer treatment outcomes: a time trade‐off study. Clin Otolaryngol 2018;43:117–123.
    1. Laccourreye O, Malinvaud D, Holsinger FC, Consoli S, Menard M, Bonfils P. Trade‐off between survival and laryngeal preservation in advanced laryngeal cancer: the otorhinolaryngology patient's perspective. Ann Otol Rhinol Laryngol 2012;121:570–575.
    1. Laccourreye O, Malinvaud D, Menard M, Consoli S, Giraud P, Bonfils P. Total laryngectomy or laryngeal preservation for advanced laryngeal cancer. Impact of the functional risk upon the patient's preferences. Eur Ann Otorhinolaryngol Head Neck Dis 2014;131:93–97.
    1. Brehaut JC, O'Connor AM, Wood TJ, et al. Validation of a decision regret scale. Med Decis Making 2003;23:281–292.
    1. Ferron Parayre A, Labrecque M, Rousseau M, Turcotte S, Legare F. Validation of SURE, a four‐item clinical checklist for detecting decisional conflict in patients. Med Decis Making 2014;34:54–62.
    1. Gattellari M, Ward JE. Will men attribute fault to their GP for adverse effects arising from controversial screening tests? An Australian study using scenarios about PSA screening. J Med Screen 2004;11:165–169.
    1. Kutner M, Greenberg E, Jin Y, Paulsen C. The health literacy of America's adults: results from the 2003 National Assessment of Adult Literacy. In: Education USDo , ed. Washington, DC: National Center for Education Statistics; 2006.
    1. Narwani V, Nalamada K, Lee M, Kothari P, Lakhani R. Readability and quality assessment of internet‐based patient education materials related to laryngeal cancer. Head Neck 2016;38:601–605.
    1. Rachet B, Quinn MJ, Cooper N, Coleman MP. Survival from cancer of the larynx in England and Wales up to 2001. Br J Cancer 2008;99(suppl 1):S35–S37.
    1. Hwang E, Johnson‐Obaseki S, McDonald JT, Connell C, Corsten M. Incidence of head and neck cancer and socioeconomic status in Canada from 1992 to 2007. Oral Oncol 2013;49:1072–1076.

Source: PubMed

3
订阅